Indivior (INDV)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$34.94+0.32%
Close 2026-09-04 · 1-day change
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · INDV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | 1,331.0 | 1,239.0 | 1,188.0 | 1,093.0 | 901.0 | — |
| Cost of Revenues | 240.0 | 246.0 | 231.0 | 174.0 | 151.0 | — |
| Gross Profit | 1,094.0 | 994.0 | 957.0 | 919.0 | 749.0 | — |
| Operating Expenses & Income | ||||||
| Selling, General & Admin | 589.0 | 634.0 | 618.0 | 565.0 | 466.0 | — |
| Operating Income | 421.0 | 262.0 | 32.0 | (152.0) | (77.0) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | 45.0 | 41.0 | — | — | — |
| Interest & Investment Income | 18.0 | 22.0 | 23.0 | 43.0 | 19.0 | — |
| Asset Writedown | — | 19.0 | 8.0 | 0.0 | 0.0 | — |
| EBT, Incl. Unusual Items | 393.0 | 239.0 | 14.0 | (145.0) | (86.0) | — |
| Income Tax Expense | 38.0 | 29.0 | 11.0 | (19.0) | (43.0) | — |
| Net Income | ||||||
| Net Income | 356.0 | 210.0 | 2.0 | (126.0) | (42.0) | — |
| Per Share | ||||||
| Basic EPS | 2.99 | 1.68 | 0.02 | (0.92) | (0.30) | — |
| Diluted EPS | 2.87 | 1.64 | 0.02 | (0.92) | (0.30) | — |
| Revenue per Share | 10.73 | — | — | — | — | — |
| Basic Weighted Avg Shares | 119.0 | 125.0 | 132.0 | 137.0 | 139.0 | — |
| Diluted Weighted Avg Shares | 124.0 | 128.0 | 133.0 | 137.0 | 139.0 | — |
| Supplemental | ||||||
| EBITDA | — | 272.0 | 61.0 | (137.0) | (61.0) | — |
| EBIT | 421.0 | 262.0 | 32.0 | (152.0) | (77.0) | — |
| Effective Tax Rate | 9.7% | — | — | 13.1% | 50.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.